Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India

During September–December 2020, we conducted a multicenter retrospective study across India to evaluate epidemiology and outcomes among cases of coronavirus disease (COVID-19)–associated mucormycosis (CAM). Among 287 mucormycosis patients, 187 (65.2%) had CAM; CAM prevalence was 0.27% among hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Atul, Agarwal, Ritesh, Rudramurthy, Shivaprakash M., Shevkani, Manoj, Xess, Immaculata, Sharma, Ratna, Savio, Jayanthi, Sethuraman, Nandini, Madan, Surabhi, Shastri, Prakash, Thangaraju, Deepak, Marak, Rungmei, Tadepalli, Karuna, Savaj, Pratik, Sunavala, Ayesha, Gupta, Neha, Singhal, Tanu, Muthu, Valliappan, Chakrabarti, Arunaloke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386807/
https://www.ncbi.nlm.nih.gov/pubmed/34087089
http://dx.doi.org/10.3201/eid2709.210934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386807/
https://www.ncbi.nlm.nih.gov/pubmed/34087089
http://dx.doi.org/10.3201/eid2709.210934

Ejemplares similares